Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors-Reference-Cited by-同舟云学术

Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors

Published:2022-09 Issue: Volume:126 Page:105883
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Ali Islam H.,Abdel-Mohsen Heba T.,Mounier Marwa M.,Abo-elfadl Mahmoud T.,El Kerdawy Ahmed M.,Ghannam Iman A.Y.^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference66 articles.

1. www.who.int/, [Last accessed on 10/05/2022].

2. Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents;Singh;Bioorg. Chem.,2021

3. RAF kinase dimerization: implications for drug discovery and clinical outcomes;Brummer;Oncogene,2020

4. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer;Roberts;Oncogene,2007

5. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy;Soltan;Eur. J. Med. Chem.,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies;Bioorganic Chemistry;2024-11

2. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09

3. Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents;Drug Development Research;2024-08-24

4. Benzimidazole‐Containing Compounds as Anticancer Agents;ChemistrySelect;2024-08-22

5. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23